Tacrine Derivatives and Alzheimer's Disease

E-ISSN： 1875-533x|17|17|1825-1838

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.17, 2010-06, pp. : 1825-1838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multifunctional Tacrine Derivatives in Alzheimer's Disease

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 15, 2013-08 ,pp. : 1771-1786

Bentham Science Publishers

Access to resources Recommend Favorite

Controlled Release Tacrine Delivery System for the Treatment of Alzheimer's Disease

By Yang Qing Williams Douglas Owusu-Ababio Godfried Ebube Nkere K. Habib Muhammad J.

Drug Delivery, Vol. 8, Iss. 2, 2001-04 ,pp. : 93-98

Informa Healthcare

Access to resources Recommend Favorite

Beyond Tacrine: Recently Developed Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease

By Unni L.K.

CNS Drugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 447-460

Adis International

Access to resources Recommend Favorite

Design of New Drugs for the Treatment of Alzheimer's Disease Based on Tacrine Structure

Current Drug Targets, Vol. 14, Iss. 3, 2013-01 ,pp. : 378-397

Bentham Science Publishers

Access to resources Recommend Favorite

Tacrine-Huperzine A Hybrids (Huprines) A New Class of Highly Potent and Selective Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer Disease

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 163-174

Bentham Science Publishers

Access to resources Recommend Favorite